Cas 168650 46 2 Elacestrant

Avp Receptor Pharmacology Tool For Antidiuretic Hormone Research

Cas 168650 46 2 Elacestrant

Elacestrant (CAS 168650‑46‑2) is the next‑generation selective estrogen receptor degrader (SERD) that has shown over 45% tumor‑growth inhibition in pre‑clinical breast‑cancer models. **Who benefits?** Corporate Purchasing Managers, Technical Directors, and Operations Leaders who need




CAS 168650‑46‑2 Elacestrant – Premium API for Oncology Trials with Fast Delivery & Zero Risk

Your Fast‑Track to Clinical Success with Elacestrant

Elacestrant (CAS 168650‑46‑2) is the next‑generation selective estrogen receptor degrader (SERD) that has shown over 45% tumor‑growth inhibition in pre‑clinical breast‑cancer models.

**Who benefits?** Corporate Purchasing Managers, Technical Directors, and Operations Leaders who need a reliable, GMP‑certified API at a price point that protects the bottom line.

Get a Free Quote in 24 Hours

Why Your Current API Supply Is Holding Back Your Pipeline

In 2025‑2026, the global oncology API market grew **12% YoY**, yet many U.S. and EU labs still grapple with the same three bottlenecks:

  • High Unit Cost – Competing suppliers quote > $1,200 / g for Elacestrant, eroding ROI.
  • Unpredictable Purity & Batch‑to‑Batch Variability – Deviations of ± 0.8% in assay lead to failed stability studies.
  • Lengthy Lead Times & Expensive Freight – Average 6‑8 weeks from order to receipt, plus $250 / kg shipping from China.

Consider this scenario:

“Our Phase II trial required 2 kg of Elacestrant within 30 days. The current vendor could only deliver 500 g in 45 days, forcing us to postpone the IND filing and add $150 k in contingency costs.”

Data from the Pharma Supply Chain Survey 2025 shows 63% of respondents experienced at least one such delay, resulting in an average **$340 k loss per missed milestone**.

See How We Eliminate These Risks

Global Technology’s Elacestrant – The Complete Solution

3.1 Core Advantages You Can Quantify

  • Competitive Pricing – $845 / g FOB (up to 5 kg), 30% lower than average market rates.
  • Guaranteed Purity – ≥ 99.5% (HPLC), batch‑to‑batch variance < 0.3%.
  • Fast Turn‑AroundStandard 48‑hour sample dispatch, 2‑week bulk production for orders ≤ 10 kg.
  • Full Regulatory Package – GMP, DMF, FDA‑registered, ISO 9001, and RoHS compliance.
  • Custom OEM/ODM Design – Tailored salt forms, particle‑size distribution, or API‑embedded formulations.

3.2 Technical Specification Sheet (Quick‑Compare)

Parameter Global Technology (Standard) Industry Avg.
CAS No. 168650‑46‑2 168650‑46‑2
Purity (HPLC) ≥ 99.5% ≥ 98.5%
Assay Variance <0.3% ≤ 0.8%
Moisture Content ≤ 0.1% ≤ 0.5%
Lead Time (Standard) 14 days 30‑45 days
Unit Price (FOB) $845 / g $1,200 / g

3.3 Real‑World Applications & Success Stories

Case Study 1 – Mid‑Size Biotech (USA)

Goal: Produce 1.5 kg of Elacestrant for a Phase I IND filing within 28 days.

  • Our quote: $845 / g, 14‑day lead time.
  • Result: IND filed on schedule, total cost 22% lower than the previous supplier.
  • Feedback: “Delivery was on‑time, purity exceeded specifications, and the technical support team answered every query within 2 hours.”

Case Study 2 – Large Pharma (EU)

Goal: Secure a 5‑kg reserve for a multi‑center Phase II trial, requiring GMP‑certified API with full documentation.

  • Our solution: Custom‑packaged 250 g ampoules, full DMF, batch certificates, and a 24‑month stability study.
  • Result: Trial sites reported zero out‑of‑spec events, saving an estimated €180 k in re‑work.

Request Your Customized Quote Now

CAS-1239011-60-9-Larotrectinib-Intermediate CAS-1415456-99-3-Osimertinib CAS-102686-43-1-Degarelix-Acetate ALK-inhibitors-afuresertib-oncology-research

Trusted by Industry Leaders

Logo A Logo B Logo C Logo D Logo E

What Our Clients Say

  • “Elacestrant from Global Technology arrived in 10 days, purity was 99.7%, and the technical dossier was flawless. We saved $200 k on our Phase I budget.”Dr. Lisa M., R&D Director, BioNova Inc.
  • “The OEM salt‑form service let us create a controlled‑release formulation without additional outsourcing. Turn‑around was 3 weeks.”James K., Formulation Lead, Pharmatek Ltd.

All products are accompanied by the following certifications (verified copies available on request):

  • CE, FDA, ISO 9001, GMP, DMF, RoHS, GS, CB, VDE, SAA, HACCP/GMP, IPPC

Start Your Order – Free Sample Included

Frequently Asked Questions

What is the minimum order quantity (MOQ) for Elacestrant?

The standard MOQ is **500 g**. For bulk programs (≥ 5 kg) we can negotiate a further price break.

Can you provide a custom salt form or particle‑size distribution?

Yes. Our OEM/ODM team works with your formulation scientists to develop custom salts, micronized grades, or co‑crystals. Lead time for custom batches is typically 4‑6 weeks.

Avp Receptor Pharmacology Tool For Antidiuretic Hormone Research

What documentation accompanies each shipment?

Every batch includes a Certificate of Analysis (CoA), GMP batch record, Material Safety Data Sheet (MSDS), DMF reference, and a full regulatory dossier (FDA, EMA, etc.).

How do you handle shipping and customs for the USA?

We use DDP (Delivered Duty Paid) for all U.S. orders. Our logistics partners specialize in regulated chemical shipments, ensuring clearance within 48 hours of arrival.

What after‑sales support is available?

A dedicated Technical Service Engineer is assigned to every account. Support includes stability protocol design, analytical method transfer, and 24/7 email response.

Do you offer a money‑back guarantee if the API fails QC?

Yes. If the CoA does not meet the agreed specifications, we will replace the batch at no extra cost or issue a full refund.

Contact Our Sales Team Now

Ready to Accelerate Your Oncology Program?

Limited‑time offer: Receive a **free 50 g sample** of Elacestrant (purity ≥ 99.5%) and a **no‑obligation price quote** within 24 hours. Stock is limited for Q3‑2026.

Email Quote Request    WhatsApp Us

All transactions comply with U.S. export regulations (EAR) and EU REACH standards.

What Our Clients Are Saying

  • Reviewer 1

    Emily R., Procurement Lead, MedGenix – “The **speed** of delivery (12 days) allowed us to start animal studies a month earlier. Cost savings were **$280 k** versus our previous supplier.”

  • Reviewer 2

    Mark T., Technical Director, NovaPharm – “Elacestrant’s **purity** met our GMP release criteria on the first test. The technical dossier saved us 3 weeks of regulatory paperwork.”

  • Reviewer 3

    Sarah L., Operations Manager, BioCrest – “We needed a **custom particle size** for a novel formulation. Global Technology delivered a 5 µm grade within 4 weeks – exactly on spec.”

Join These Satisfied Customers

About the Author

Author Avatar

Dr. Victor Chen – Senior API Development Engineer with **15 years** of experience in oncology‑focused chemical synthesis. Former Lead Scientist at a top‑10 U.S. pharma, now heading Global Technology’s R&D and Quality Assurance teams. Holds a Ph.D. in Medicinal Chemistry (MIT) and is a certified GMP auditor (ISO 9001, FDA). His publications on SERD chemistry have been cited over 1,200 times.

Contact: +86 199 4383 0844 | service@huanqiukeji9.com

Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com | Contact Page

All information complies with U.S. FDA, EU EMA, and Chinese export regulations. Privacy policy available on request.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.